Stocks
Regulatory Wins and M&A Deals Dominate Biotech Week
Johnson & Johnson (JNJ) received CE Marking for its ACUVUE OASYS MAX 2-Week reusable contact lenses, expanding its eye care portfolio. The lens will launch in select European markets later this year and reach a broader rollout in 2027.
GSK plc (GSK) gained Japanese approval for a new pre-filled syringe presentation of its shingles vaccine Shingrix, which aims to improve convenience and broaden access for adults at risk of shingles.
Axogen Inc. (AXGN) announced it will acquire BioCircuit Technologies, an advanced neural interface developer, in a $200 million cash deal expected to close in Q4.